Skip to main content
Fig. 2 | European Journal of Medical Research

Fig. 2

From: Identification of ACBD3 as a new molecular biomarker in pan-cancers through bioinformatic analysis: a preclinical study

Fig. 2

The expression level of ACBD3 in different tumors and normal tissues (*p < 0.05, **p < 0.01, ***p < 0.001) and corresponding immunohistochemistry images. A ACBD3 expression was statistically upregulated in breast invasive carcinoma (BRCA), B ACBD3 expression was statistically upregulated in liver hepatocellular carcinoma (LIHC), C ACBD3 expression was statistically upregulated in lung adenocarcinoma (LUAD), D ACBD3 expression was statistically downregulated in kidney chromophobe (KICH)

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us